Topic summary

How shortages have affected compounding permissions — does this still hold?

Access › Shortages compounding shortage formulary FDA Solved

This is a generated summary. It shows the 5 most-liked posts from a topic of 32, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

v.klausenTL3Regular16 May 2026#3

Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration discussion with a clinician.

25 likes 2mo

v.salgadoTL2 Moderator Solution4 Jun 2026#9

post #8 is right about the mechanism and I think understates the practical bit.

Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and time-limited (usually for the duration of the shortage).

7 likes 2mo

c.correiaTL2 Moderator12 Jun 2026#12

f.petrov, post #6: Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for planning. Go to post

Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are different decisions.

22 likes in reply to #6 2mo

a.westergaardTL3Regular22 Jun 2026#16

v.salgado, post #9: post #8 is right about the mechanism and I think understates the practical bit. Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and time-limited (usually for the duration of the shortage). Go to post

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

29 likes in reply to #9 1mo

ra.mensaTL2 Moderator29 Jun 2026#19

Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.

23 likes 29d

Read the full topic (32 posts)

This topic was referenced in

Managing an unplanned gap in supplyAccess › Shortages · 110 replies

Suggested topics

Topic	Participants	Replies	Views	Activity
Coming back to: Official shortage notices and what they authorise Access › Shortages shortage FDA formulary Solved Closed Official shortage notices and what they authorise — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines…	+39	43	510	17mo
About the Shortages category Access › Shortages shortage compounding FDA Pinned Wiki Supply interruptions, official shortage notices, and managing an unplanned gap. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and…	+3	7	9.9k	1d
Hoarding and why it makes a shortage worse Access › Shortages formulary shortage compounding FDA Posting this under the heading it deserves: Hoarding and why it makes a shortage worse Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…		2	12k	22mo
Coming back to: Official shortage notices and what they authorise Access › Shortages FDA compounding shortage formulary Official shortage notices and what they authorise Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail included, since that is what…	+85	92	5.5k	11mo
Second pass at: Hoarding and why it makes a shortage worse Access › Shortages FDA compounding shortage Second pass at: Hoarding and why it makes a shortage worse Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in this…	+115	133	11k	21mo

Related topics — sharing the tags compounding, shortage, formulary

Topic	Participants	Replies	Views	Activity
Tracking a shortage from primary sources rather than rumour Access › Shortages shortage FDA formulary Tracking a shortage from primary sources rather than rumour — setting out what I have, and where I think it stops being reliable. Documenting an access outcome, dated, because everything in this category…	+121	126	35k	13h
[2026 update] EU-wide position versus national implementation Regional › European Union personal import cost per milligram formulary EMA Solved On the subject in the title: EU-wide position versus national implementation Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires. As of…		2	54k	19mo
EU-wide position versus national implementation Regional › European Union EMA personal import cost per milligram formulary Solved Under review EU-wide position versus national implementation Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in this category…	+22	29	356	11mo
Prescription requirements and telehealth models — a second dataset Sourcing › Regulatory compounding EMA MHRA personal import On the subject in the title: Prescription requirements and telehealth models — a second dataset Working notes rather than a conclusion. A logistics question, since the answers here are usually better than…	+87	94	1.1k	21d
[2026 update] An appeal that failed, and what I would do differently Access › Insurance & coverage prior authorisation insurance formulary Posting this under the heading it deserves: An appeal that failed, and what I would do differently Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this…	+152	159	2.5k	13mo